Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Hmga2 promotes the development of myelofibrosis in Jak2 V617F knockin mice by enhancing TGF-β1 and Cxcl12 pathways

Avik Dutta, Robert E. Hutchison, Golam Mohi

Blood (2017) 130 (7): 920–932.

https://doi.org/10.1182/blood-2016-12-757344

Published: 2017

Includes: Supplemental data

Journal Articles

Deletion of PTPN1 Promotes the Development of Myelofibrosis

Fatoumata Jobe, PhD, Bhumika Patel, MD, Hideki Makishima, MD PhD, Bartlomiej P Przychodzen, MSc, Robert E Hutchison, MD, Kendra K Bence, PhD, Jaroslaw P Maciejewski, MD PhD FACP, Golam Mohi, PhD

Blood (2016) 128 (22): 795.

https://doi.org/10.1182/blood.V128.22.795.795

Published: 2016

Journal Articles

Expression of HMGA2 Cooperates with Jak2V617F in the Development of Myelofibrosis

Avik Dutta, MSc, Robert E Hutchison, MD, Golam Mohi, PhD

Blood (2016) 128 (22): 797.

https://doi.org/10.1182/blood.V128.22.797.797

Published: 2016

Journal Articles

Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm

Yue Yang, Hajime Akada, Dipmoy Nath, Robert E. Hutchison, Golam Mohi

Blood (2016) 127 (26): 3410–3423.

https://doi.org/10.1182/blood-2015-11-679431

Published: 2016

Includes: Supplemental data

Journal Articles

Critical Role of SHP2 in the Initiation and Maintenance of Myeloproliferative Neoplasms Evoked By JAK2V617F

Golam Mohi, PhD, Dongqing Yan, PhD, Fatoumata Jobe, Robert E Hutchison, MD

Blood (2015) 126 (23): 483.

https://doi.org/10.1182/blood.V126.23.483.483

Published: 2015

Journal Articles

Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study

Mihai Merzianu, MD, Richard Cheney, MD, Adrienne Groman, MS, George Deeb, MD, Gregory Wilding, PhD, Claudiu Cotta, MD, Ramila Amre, MD, Manjula Balasubramanian, MD, Guilherme Brandao, MD, Russell K. Brynes, MD, Sindhu Cherian, MD, Elizabeth Courville, MD, David Czuchlewski, MD, Guang Fan, MD PhD, David Grier, MD, Daniela Hoehn, MD PhD, Robert E Hutchison, MD, Kedar V. Inamdar, MD PhD, Ridas Juskevicius, MD, Prabhjot Kaur, MD, John Lazarchick, MD, Michael R Lewis, MD, Rodney R. Miles, MD PhD, Jerome B. Myers, MD PhD, Michel Nasr, MD, Hina Naushad, MD, Horatiu Olteanu, MD PhD, Attilio Orazi, MD, Vishnu VB Reddy, MD, Valentin G Robu, MD, Gratian Salaru, MD, Julie Teruya-Feldstein, MD, Neerja Vajpayee, MD, Jeffrey Vos, MD, Ling Zhang, MD, Shanxing Zhang, MD PhD, Ashley V Sedelmeyer, MHA, Vivian Arguello, MD, Le Aye, DO, Sharon Barouk, MA, Elisa F Brega, MD PhD, Richie Carpenter, BS, James E. Coad, MD, Alana DiPonio, MT, Fernandez Garcia, MS, MD, John Grantham, BS, Sinisa Ivelja, MD, Robert McKenna, MD, Kieran Sultan, MD, Matthew B Thomsen, MPH, Jie Xu, MD PhD, LoAnn Peterson, MD, Vishala T. Neppalli, MD

Blood (2014) 124 (21): 1316.

https://doi.org/10.1182/blood.V124.21.1316.1316

Published: 2014

Journal Articles

Loss of EZH2 Inhibits Erythropoiesis and Accelerates the Development of Myelofibrosis in Jak2V617F Knock-in Mice

Yue Yang, Hajime Akada, PhD, Dipmoy Nath, Robert E Hutchison, MD, Golam Mohi, PhD

Blood (2014) 124 (21): 159.

https://doi.org/10.1182/blood.V124.21.159.159

Published: 2014

Journal Articles

Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice

Dongqing Yan, Robert E. Hutchison, Golam Mohi

Blood (2012) 120 (9): 1888–1898.

https://doi.org/10.1182/blood-2011-09-380808

Published: 2012

Includes: Supplemental data

Journal Articles

Efficacy of vorinostat in a murine model of polycythemia vera

Hajime Akada, Saeko Akada, Ajeet Gajra, Alicia Bair, Stephen Graziano, Robert E. Hutchison, Golam Mohi

Blood (2012) 119 (16): 3779–3789.

https://doi.org/10.1182/blood-2011-02-336743

Published: 2012

Includes: Supplemental data

Journal Articles

Critical requirement for Stat5 in a mouse model of polycythemia vera

Dongqing Yan, Robert E. Hutchison, Golam Mohi

Blood (2012) 119 (15): 3539–3549.

https://doi.org/10.1182/blood-2011-03-345215

Published: 2012

Includes: Supplemental data

Journal Articles

Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera–like disease

Hajime Akada, Dongqing Yan, Haiying Zou, Steven Fiering, Robert E. Hutchison, M. Golam Mohi

Blood (2010) 115 (17): 3589–3597.

https://doi.org/10.1182/blood-2009-04-215848

Published: 2010

Includes: Supplemental data

Journal Articles

Conditional Expression of Heterozygous or Homozygous Jak2V617F From Its Endogenous Promoter Induces a Polycythemia Vera-Like Disease.

Hajime Akada, Dongqing Yan, Haiying Zou, Robert E. Hutchison, M. Golam Mohi, PhD

Blood (2009) 114 (22): 437.

https://doi.org/10.1182/blood.V114.22.437.437

Published: 2009

Journal Articles

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425

Cindy L. Schwartz, Louis S. Constine, Doojduen Villaluna, Wendy B. London, Robert E. Hutchison, Richard Sposto, Steven E. Lipshultz, Charles S. Turner, Pedro A. deAlarcon, Allen Chauvenet

Blood (2009) 114 (10): 2051–2059.

https://doi.org/10.1182/blood-2008-10-184143

Published: 2009

Includes: Supplemental data

Journal Articles

Adult Patients With De Novo Acute Myeloid Leukemia and t(9; 11)(p22; q23) Have a Superior Outcome to Patients With Other Translocations Involving Band 11q23: A Cancer and Leukemia Group B Study

Krzysztof Mrózek, Kristiina Heinonen, David Lawrence, Andrew J. Carroll, Prasad R.K. Koduru, Kathleen W. Rao, Matthew P. Strout, Robert E. Hutchison, Joseph O. Moore, Robert J. Mayer, Charles A. Schiffer, Clara D. Bloomfield

Blood (1997) 90 (11): 4532–4538.

https://doi.org/10.1182/blood.V90.11.4532

Published: 1997

NARROW

Hmga2 promotes the development of myelofibrosis in Jak2 V617F knockin mice by enhancing TGF-β1 and Cxcl12 pathways

Deletion of PTPN1 Promotes the Development of Myelofibrosis

Expression of HMGA2 Cooperates with Jak2V617F in the Development of Myelofibrosis

Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm

Critical Role of SHP2 in the Initiation and Maintenance of Myeloproliferative Neoplasms Evoked By JAK2V617F

Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study

Loss of EZH2 Inhibits Erythropoiesis and Accelerates the Development of Myelofibrosis in Jak2V617F Knock-in Mice

Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice

Efficacy of vorinostat in a murine model of polycythemia vera

Critical requirement for Stat5 in a mouse model of polycythemia vera

Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera–like disease

Conditional Expression of Heterozygous or Homozygous Jak2V617F From Its Endogenous Promoter Induces a Polycythemia Vera-Like Disease.

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425

Adult Patients With De Novo Acute Myeloid Leukemia and t(9; 11)(p22; q23) Have a Superior Outcome to Patients With Other Translocations Involving Band 11q23: A Cancer and Leukemia Group B Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only